skip to Main Content

Half of Cannabis Executives Slash Revenue Forecasts Due to Coronavirus, Reallocating Marketing Budgets to Digital Media and Virtual Events

New study quantifies the impact of COVID-19, with 56% of executives moving marketing spend to online events and digital media and 39% planning to scale-back staffing. Cannabis executives report slashing budgets and significant disruption to suppliers and services during the…

Read More

FSD Pharma Receives U.S. FDA Approval to Design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

PRESS RELEASE TORONTO--(BUSINESS WIRE)-- FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application…

Read More
Back To Top
×Close search
Search